10,200 Shares in Avanos Medical, Inc. (NYSE:AVNS) Bought by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS purchased a new stake in Avanos Medical, Inc. (NYSE:AVNS) in the fourth quarter, HoldingsChannel reports. The fund purchased 10,200 shares of the company’s stock, valued at approximately $162,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Quarry LP acquired a new position in shares of Avanos Medical during the third quarter valued at about $42,000. Quantbot Technologies LP acquired a new position in Avanos Medical in the 4th quarter valued at approximately $64,000. EP Wealth Advisors LLC bought a new stake in shares of Avanos Medical in the 3rd quarter worth approximately $212,000. US Bancorp DE lifted its position in shares of Avanos Medical by 18.0% in the 4th quarter. US Bancorp DE now owns 14,093 shares of the company’s stock worth $224,000 after acquiring an additional 2,147 shares during the period. Finally, Zacks Investment Management acquired a new stake in shares of Avanos Medical during the 3rd quarter worth approximately $335,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares of the company’s stock, valued at approximately $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.64% of the company’s stock.

Avanos Medical Stock Down 4.4 %

Shares of AVNS opened at $12.37 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average price of $15.21 and a two-hundred day moving average price of $17.76. The stock has a market cap of $568.92 million, a price-to-earnings ratio of 36.37 and a beta of 1.15. Avanos Medical, Inc. has a 12 month low of $12.28 and a 12 month high of $25.36.

Avanos Medical (NYSE:AVNS) last posted its earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.40 by $0.03. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Equities analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 19th.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.